The proportional reductions in mortality were not significantly different between patients with prior comorbidities, HF, or KILIP class >1 at entry, as opposed to those without it or KILIP class 1, but absolute benefits of ACE inhibitor treatment were greater among those groups, which implies that patients at higher risk generally benefit to a greater absolute extent. Here, ACE is linked to hydrops fetalis.